BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15330191)

  • 1. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
    Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
    Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
    Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-, beta- and chi-catenin expression in human pancreatic cancer.
    Julkunen K; Mäkinen K; Kärjä V; Kosma VM; Eskelinen M
    Anticancer Res; 2003; 23(6D):5043-7. PubMed ID: 14981965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
    Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM
    Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and catenins in early squamous cervical carcinoma.
    Van de Putte G; Kristensen GB; Baekelandt M; Lie AK; Holm R
    Gynecol Oncol; 2004 Aug; 94(2):521-7. PubMed ID: 15297198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer.
    Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
    Anticancer Res; 2005; 25(6C):4707-12. PubMed ID: 16334164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
    Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
    Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of beta-catenin in renal cell carcinoma.
    Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
    Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
    Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
    Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].
    Zhou YN; Li M
    Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma.
    Imura J; Ichikawa K; Takeda J; Fujimori T
    Int J Mol Med; 2001 Oct; 8(4):353-8. PubMed ID: 11562771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
    Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
    Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
    Ramburan A; Hadley GP; Govender D
    Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
    Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
    Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
    J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.